Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 15 Neoplasms 3 Sarcoma 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 Uterine Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Recurrence 1 Peritoneal Neoplasms 1 Ovarian Epithelial Cancer Recurrent 1 Ovarian Diseases 1 Neurofibrosarcoma 1 Neoplasms by Site 1 Malignant mesenchymal tumor 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Hemangiopericytoma, Malignant 1 Genital Diseases, Female 1 Gastrointestinal Stromal Tumors 1 Fibrosarcoma 1 Fanconi Anemia, Complementation Group D1 1 Endocrine Gland Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma 1

Interventions

Carboplatin 19 Paclitaxel 17 Cisplatin 9 Gemcitabine 7 Cyclophosphamide 7 Bevacizumab 6 Topotecan 5 pembrolizumab 4 olaparib 4 liposomal doxorubicin 4 durvalumab 4 Letrozole 4 Interleukin-2 4 Drug Therapy 4 Doxorubicin 4 Albumin-Bound Paclitaxel 4 rucaparib 3 fludarabine 3 chiauranib 3 cemiplimab 3 camrelizumab 3 Therapeutics 3 Itraconazole 3 Injections 3 Hyperthermic Intraperitoneal Chemotherapy 3 Everolimus 3 pazopanib 2 iniparib 2 eprenetapopt 2 avelumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Trabectedin × Gynecologic × Clear all

NCT03164980 2025-03-20

COMPASS

North Eastern German Society of Gynaecological Oncology

Phase 4 Terminated

89 enrolled 20 charts

Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡